MyD88 and TLR4 Expression in Epithelial Ovarian Cancer
Matthew S. Block(Mayo Clinic in Arizona), Georgia Chenevix‐Trench(QIMR Berghofer Medical Research Institute), Hans‐Peter Sinn(Heidelberg University), Janusz Menkiszak(Pomeranian Medical University), Oleg Oszurek(International Hereditary Cancer Center), Weiva Sieh(The University of Texas MD Anderson Cancer Center), Florin‐Andrei Taran(University Children's Hospital Tübingen), Allan Jensen(Danish Cancer Society), Daniel Guimarães Tiezzi(Mayo Clinic), Bryan M. McCauley(University of Minnesota), Teresa Ramón y Cajal(Hospital de Sant Pau), Sharon E. Johnatty(QIMR Berghofer Medical Research Institute), Robert A. Vierkant(Mayo Clinic), Jan Lubiński(Tumour Institute of Tuscany), Stacey J. Winham(Mayo Clinic), Anita Chudecka-Głaz(Pomeranian Medical University), Brenda Y. Hernandez(Cancer Center of Hawaii), Gregg Nelson(Brigham and Women's Hospital), Andreas D. Hartkopf(University of Tübingen), Jose Maria Garcia-Bueno(Hospital General Universitario de Albacete), Peter Rambau(Catholic University of Health and Allied Sciences), Prafull Ghatage(University of Calgary), Catherine J. Kennedy(The University of Sydney), Philipp Wagner(University Children's Hospital Tübingen), Sián Fereday(Peter MacCallum Cancer Centre), Kimberly R. Kalli(Mayo Clinic), Marie Mack(University of Cambridge), Maria P. Intermaggio(The University of Melbourne), Valerie McGuire(Cargill (Netherlands)), Audrey Jung(German Cancer Research Center), Bo Gao(Sun Yat-sen University), Paul R. Harnett(The University of Sydney), Sandra Oršulić(Cedars-Sinai Medical Center), Francesmary Modugno(University of Pittsburgh), Aleksandra Tołoczko(International Hereditary Cancer Center), Esther Herpel(Memorial Sloan Kettering Cancer Center), Jenny Lester, Raghwa Sharma(Royal Prince Alfred Hospital), Teri A. Longacre(Palo Alto University), Jurandyr Moreira de Andrade(Universidade de São Paulo), Zheng Li(Uppsala University), Luis Paz‐Ares(Hospital Universitario 12 De Octubre), Joseph H. Rothstein(University of Washington Medical Center), Roberta B. Ness(The University of Texas Health Science Center at Houston), Christiani Bisinoto de Sousa(Universidade de São Paulo), Ursula Eilber(University of Helsinki), Jillian A. Hung(Millennium Institute), Nadia Traficante(The University of Melbourne), Robert P. Edwards(Magee-Womens Research Institute), Mercedes Jimenez‐Liñan(University of Kansas)
Cited by 30
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
<i>ARID1A</i> Mutations in Endometriosis-Associated Ovarian Carcinomas
|New England Journal of Medicine|2010|1.7k
Whole–genome characterization of chemoresistant ovarian cancer
|Nature|2015|1.7k